You are here
- Home
- Therapy Areas
- Neuroscience
Rapid Dose Escalation of Quetiapine versus Conventional Escalation in the Treatment of Patients with Acute Schizophrenia, a Multicentre, Double-blind, Parallel group, Randomized Study
- Disease
- schizophrenia
- Drug Name
- Seroquel
- Generic Name
- quetiapine
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- II
- Start Date
- Jun 15, 2005
- Study Name
- D1441L00032
- Study Id
- D1441L00032
- ClinicalTrials.gov ID
- NCT00254787
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
